Shattuck Labs Announces Participation in Needham's 20th Annual Healthcare Conference
AUSTIN, TX and DURHAM, NC, April 06, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced it will participate in Needham’s 20th Annual Healthcare Conference being held virtually April 12-15, 2021.
A live webcast will be available on the Events & Presentations section of the Company’s website. A replay of the webcast will be archived for up to 90 days following the presentation date.
About Shattuck Labs, Inc.
Why AIOps is an Option
Sales and Marketing For Independent Provider of Cloud Voice Services